Abstract
The importance of true worsening renal failure (WRF), which is associated with a poor prognosis, had been suggested in patients with acute heart failure (AHF). The aim of the present study was to establish the biomarker strategy for the prediction of true WRF in AHF. Two hundred eighty-one patients with AHF were analysed. Their biomarkers were measured within 30 min of admission. Patients were assigned to the non-WRF (n = 168), pseudo-WRF (n = 56), or true-WRF (n = 57) groups using the criteria of both acute kidney injury on admission and increasing serum creatinine value during the first 7 days. A Kaplan-Meier curve showed that the survival and heart failure event rate of the true-WRF group within 1000 days was significantly lower than that of the non-WRF and pseudo-WRF groups (P ≤ 0.001). The multivariate Cox regression model also indicated that true WRF was an independent predictor of 1000 day mortality and heart failure events [hazard ratio: 4.315, 95% confidence interval (CI): 2.466-7.550, P ≤ 0.001, and hazard ratio: 2.834, 95% CI: 1.893-4.243, P ≤ 0.001, respectively]. The serum heart-type fatty acid-binding protein (s-HFABP) levels were significantly higher in the true-WRF group than in the non-WRF and pseudo-WRF groups...Continue Reading
References
Nov 15, 1992·The Biochemical Journal·R G MaatmanJ H Veerkamp
Feb 1, 1991·The Biochemical Journal·R G MaatmanJ H Veerkamp
Jan 1, 1990·Drugs·S LjungmanR J Cody
Jun 9, 1993·Molecular and Cellular Biochemistry·J H Veerkamp, H T van Moerkerk
Jan 13, 2004·Journal of the American College of Cardiology·Daniel E FormanHarlan M Krumholz
Sep 18, 2004·The American Journal of Cardiology·Senthil K ThambidoraiAllan L Klein
Jan 18, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·Maurice M A L PelsersJan F C Glatz
Nov 5, 2005·Clinical Chemistry·Hassan M E AzzazyRobert H Christenson
Apr 21, 2006·European Heart Journal·Martin R CowieUNKNOWN POSH Investigators
Feb 19, 2008·European Journal of Heart Failure·Marco MetraLivio Dei Cas
Apr 19, 2008·Internal Medicine·Kunitoshi Iseki
Nov 15, 2008·Journal of the American College of Cardiology·Claudio RoncoRinaldo Bellomo
Feb 14, 2009·Journal of the American College of Cardiology·Wilfried MullensW H Wilson Tang
Dec 22, 2009·European Journal of Heart Failure·Noritake HataYasuhiro Takahashi
Jun 12, 2010·The American Journal of Cardiology·Robb D KociolAdrian F Hernandez
Jul 6, 2010·American Heart Journal·Uptal D PatelLesley H Curtis
Nov 3, 2010·Annals of Surgery·Ina JochmansJacques Pirenne
Dec 15, 2011·Circulation. Heart Failure·Marco MetraLivio Dei Cas
Oct 3, 2012·PloS One·Hui-Mei ChenZhi-Hong Liu
Oct 6, 2012·International Heart Journal·Akihiro ShirakabeKyoichi Mizuno
Dec 5, 2012·Circulation Journal : Official Journal of the Japanese Circulation Society·Akihiro ShirakabeKyoichi Mizuno
Jun 15, 2015·BMC Cardiovascular Disorders·Ursula HoffmannMichael Behnes
May 22, 2016·European Journal of Heart Failure·Piotr PonikowskiUNKNOWN Document Reviewers
Jan 31, 2017·European Journal of Heart Failure·Mateusz SokolskiPiotr Ponikowski
Feb 2, 2018·ESC Heart Failure·Akihiro ShirakabeWataru Shimizu
Citations
Oct 4, 2019·Biomarkers in Medicine·Leili PourafkariNader D Nader
Jan 16, 2020·Journal of Clinical Medicine·Richard RezarMichael Lichtenauer
Sep 24, 2020·Nanoscale·Mehmet Lütfi Yola, Necip Atar
Aug 14, 2020·Journal of Clinical Medicine·Barbara InfanteGiovanni Stallone
Jun 19, 2019·Heart Failure Reviews·Xiaofeng ShiYue Zhang
Nov 27, 2019·Current Heart Failure Reports·Alexander S MangubaAnuradha Lala
Apr 24, 2021·BMC Cardiovascular Disorders·Jiajia Zhu, Wenxian Liu
May 25, 2021·Heart and Vessels·Kenichi TaniWataru Shimizu
Jul 20, 2021·International Heart Journal·Akihiro ShirakabeWataru Shimizu
Oct 20, 2021·Clinica Chimica Acta; International Journal of Clinical Chemistry·Michael A VeraJoe M El-Khoury